These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26093634)

  • 1. Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.
    Ahlgren HG; Benedetti A; Landry JS; Bernier J; Matouk E; Radzioch D; Lands LC; Rousseau S; Nguyen D
    BMC Pulm Med; 2015 Jun; 15():67. PubMed ID: 26093634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
    Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
    mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
    Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
    J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
    Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
    Maliniak ML; Stecenko AA; McCarty NA
    J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
    Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
    J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
    Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
    PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
    Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
    Emerson J; McNamara S; Buccat AM; Worrell K; Burns JL
    Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes.
    Shteinberg M; Rivlin J; Gur M; Konopnicki M; Stein N; Tunney MM; Elborn JS; Downey DG; Johnston E; Shalom H; Levy A
    Lung; 2015 Dec; 193(6):1017-21. PubMed ID: 26370551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
    Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.
    Somayaji R; Waddell B; Workentine ML; Surette MG; Brager NP; Rabin HR; Parkins MD
    BMC Pulm Med; 2015 Nov; 15():138. PubMed ID: 26542115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis.
    Sharma GD; Tosi MF; Stern RC; Davis PB
    Am J Respir Crit Care Med; 1995 Jul; 152(1):169-73. PubMed ID: 7599818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.